In The Affair, Helen Solloway's Cancer Story Is Actually Her Partner's

Maura Tierney's Helen Solloway spent five seasons of Showtime's "The Affair" absorbing other people's disasters. There was an unraveling marriage, a suicide, a prison sentence. The cancer storyline that hit her hardest wasn't hers, though. It belonged to Vik Ullah, the man she was building a new life with after leaving Noah. In the show's fourth season, Helen and Vik learn he has late-stage pancreatic cancer. He does not want treatment for it.

What follows is less a medical drama than a study. It shows what it looks like to love someone through a terminal diagnosis, while still trying to hold together a household, a career, and four kids.

That distinction matters for anyone searching for "Helen Solloway cancer" expecting a breast cancer plotline. It doesn't exist. What "The Affair" actually shows is a partner absorbing a terminal diagnosis that isn't her own. That's arguably a more common experience than a personal diagnosis. It's one TV rarely slows down to show in detail.

Why pancreatic cancer is so often caught late

Vik's diagnosis tracks with a real and grim feature of pancreatic cancer: it is often caught late. The pancreas sits deep in the belly. Early tumors often cause few or no symptoms. So a large share of cases aren't found until the cancer has already spread beyond the pancreas. The National Cancer Institute says exocrine pancreatic cancer — the far more common form — tends to be found at an advanced stage. The rarer neuroendocrine form generally has a better outlook. That split helps explain why "pancreatic cancer" can mean very different things for a person's outlook, depending on which type they have.

The show is also realistic in a quieter way: Vik's choice to decline treatment.

Real cancer-care talks, especially around late-stage disease, often include an honest look at what chemo or surgery can and can't really do. They cover how much time and quality of life a given plan might buy, and whether a patient prefers comfort-focused care instead.

Declining aggressive treatment isn't giving up. For some patients with advanced pancreatic cancer, it's a considered choice about how they want to spend the time they have.

Helen's disorientation, guilt, and exhaustion also ring true, as she tries to support that choice while parenting and working. Caregiver strain is one of the best-documented parts of a cancer diagnosis. It rarely gets its own storyline, though.

What five seasons of TV can't show about the timeline

Television compresses time by necessity, and "The Affair" is no exception. A season of episodic drama can make a diagnosis-to-decline-to-death arc feel like it unfolds over weeks. In reality, advanced pancreatic cancer courses vary a lot. Some patients live many months or longer with treatment. Others decline faster. The show also doesn't dwell on the real workup: imaging, biopsy, staging scans, and team talks (oncology, comfort care, sometimes surgery) that typically come before a treatment decision. Skipping that process is standard for drama. But it can leave viewers with a false sense of how quickly or loosely these decisions actually get made.

It's also worth remembering that Vik's story is one man's course through one type of cancer. Outlook for pancreatic cancer depends heavily on stage at diagnosis, tumor spot, whether it can be removed by surgery, and a patient's overall health. No single character's arc can stand in for everyone facing the disease.

Warning signs that are easy to miss

Pancreatic cancer's early symptoms are famously vague and easy to blame on something else. They include unexplained weight loss, belly or back pain, new or worsening diabetes, jaundice (yellowing skin or eyes), pale stools, or dark urine. Nearly all of these have far more common, non-cancer causes — reflux, gallstones, stress, diet changes. That's exactly why the disease is so often missed until it has advanced. Having one of these symptoms is not a diagnosis. It's a reason to see a doctor and ask questions, not a reason for alarm on its own.

Why there's no routine screening test

There's no routine screening test for pancreatic cancer for the whole population, the way there is for breast or colon cancer. That's mostly because it isn't common enough, and no test is accurate enough, to justify screening everyone.

Awareness instead centers on risk factors that can be changed. Smoking is one of the strongest, along with obesity, heavy alcohol use, long-term pancreatitis, and long-standing diabetes. Family history matters too, since a minority of cases run in families with certain inherited gene changes.

People with a strong family history or a known genetic syndrome may be candidates for special watch through a genetics or high-risk clinic. But this isn't the same as routine screening for the public, and nothing here can promise prevention.

Helen's experience as a partner, not a patient, is also a reminder. Cancer's reach extends well past the person diagnosed. Caregivers face their own risks — sleep loss, depression, worry, and money strain — and deserve support and information just as much as patients do.

Stories like this one reach people at a moment when they're scared, searching, or trying to understand what someone they love is going through. Keeping clear, accurate, source-linked explanations of diseases like pancreatic cancer free and ad-free is exactly the kind of work nonprofit health groups exist to do. It depends on readers who value it choosing to support it.

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.